<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="17679">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02876744</url>
  </required_header>
  <id_info>
    <org_study_id>MMT_2016_21</org_study_id>
    <nct_id>NCT02876744</nct_id>
  </id_info>
  <brief_title>Correlation Between Macular Ischemia and Peripheral Ischemia in Patients With Diabetes</brief_title>
  <acronym>CORISMAP</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Fondation Ophtalmologique Adolphe de Rothschild</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fondation Ophtalmologique Adolphe de Rothschild</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The contribution of OCT- angiography (OCT-A) allows to consider, in a more or less long
      term, a drastic reduction in the use of fluorescein angiographies in diabetic retinopathy.
      The accuracy of the analysis of the vascularization of retinal layers of the posterior pole
      of the eye by the OCT-A , will detect, early and in a quantifiable manner, whether or not
      there are areas of macular ischemia in a patient. However, current technical limitations
      (small field analysis) of OCT-A imaging only allow a limited study of retina at the
      posterior pole of the fundus.

      This study seeks to demonstrate whether there is a link between macular ischemia detected by
      the OCT-A and peripheral retinal ischemia detected by the fluorescein angiographies, in
      diabetic patients.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <primary_completion_date type="Anticipated">September 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Detection and measure of ischemic territories in central and peripheral retina</measure>
    <time_frame>immediate</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diabetic Retinopathy</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ophthalmologic examination including optical coherent tomography with angiography module.</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with diabetes, requiring follow-up with fluorescein angiography.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diabetes type I or type II

          -  follow-up with fluorescein angiography

        Exclusion Criteria:

          -  known allergy to fluorescein

          -  contra-indication to fluorescein angiography

          -  pregnant or breast-feeding patient

          -  technical impossibility to analyse retinal ischemic areas on fluorescein angiography
             or OCT-A.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Laurence SALOMON, MD, PhD</last_name>
    <phone>0033148036431</phone>
    <email>lsalomon@for.paris</email>
  </overall_contact>
  <verification_date>August 2016</verification_date>
  <lastchanged_date>August 23, 2016</lastchanged_date>
  <firstreceived_date>August 19, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diabetic Retinopathy</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
